Table 3.
Clinical conditions of infective endocarditis
| Patients without in-hospital mortality (n=89) | Patients with in-hospital mortality (n=18) | P-value | |
|---|---|---|---|
| Peripheral embolism, n (%) | 1 (1.1) | 0 (0) | 0.832 |
| Immune phenomena, n (%) | 3 (3.4) | 1 (5.6) | 0.527 |
| Vascular phenomena, n (%) | 14 (15.7) | 4 (22.2) | 0.355 |
| Vegetation, n (%) | 68 (76.4) | 13 (76.5) | 0.633 |
| Vegetation, n (%) | |||
| Aortic | 32 (36.0) | 10 (58.8) | 0.077 |
| Mitral | 40 (44.9) | 5 (29.4) | 0.235 |
| Tricuspid | 5 (5.6) | 0 (0) | 0.410 |
| Intracardiac device | 1 (1.1) | 0 (0) | 0.840 |
| Mobility | 56 (83.6) | 8 (66.7) | 0.163 |
| Vegetation size, n (%) | |||
| <10 | 30 (25.3) | 1 (5.9) | |
| 10–15 | 22 (27.8) | 7 (41.2) | 0.188 |
| >15 | 37 (46.8) | 9 (52.9) | |
| Ischemic infarct | 6 (6.7) | 1 (5.6) | 0.665 |
| Hemorrhagic infarct | 3 (3.4) | 0 (0) | 0.572 |
| Septic embolism | 2 (2.2) | 0 (0) | 0.691 |
| Subdural hematoma | 0 (0) | 1 (5.6) | 0.168 |
| High-risk group, n (%) | 31 (34.8) | 9 (50.0) | 0.225 |
| Positive blood culture, n (%) | 41 (46.1) | 14 (77.8) | 0.014 |
| Streptokok | 7 (17.1) | 1 (7.1) | 0.014 |
| Stenotrophomonas maltophilia | 1 (2.4) | 1 (7.1) | |
| Serratia marcescens | 1 (2.4) | 0 (0) | |
| Psödomonas | 1 (2.4) | 0 (0) | |
| MSSA | 3 (7.3) | 3 (21.4) | |
| MSKNS | 9 (22.0) | 2 (14.3) | |
| MRSA | 3 (7.3) | 0 (0) | |
| MRKNS | 9 (22.0) | 5 (35.7) | |
| Enterococcus faecalis | 4 (9.8) | 0 (0) | |
| Escherichia coli | 0 (0) | 1 (7.1) | |
| Corynebacterium striatum | 1 (2.4) | 0 (0) | |
| Candida | 1 (2.4) | 1 (7.1) | |
| Brucella | 1 (2.4) | 0 (0) |
MRKNS: Methicillin-resistant coagulase-negatıve Staphylococcus,; MRSA: Methicillin-resistant Staphylococcus aureus; MSKNS: Methicillin-sensitive coagulase-negative Staphylococcus; MSSA: Methicillin sensitive Staphylococcus aureus.